Ruby R. Kapadia, Do, Ms Email and Phone Number

CEO Physician: Double Board Certified Family Medicine &Addiction Medicine Large Clinical Practice 10 + years of Clinical ExperienceSpecializes in Complex Eating Disorders, Obesity Medicine. Biotech Pharma Research & Development Excellent Communication & Presentation SkillsManchester Board of Education PhysicianGeriatric Attending Faculty Rowan Medical D.O. (Doctor of Osteopathic Medicine) / Physician with Masters in Biotech EngineeringMedical training/experienceExperience in Medical Affairs, Pipeline Compound Development and/or Medical Affairs function of a Global Healthcare Organization or equivalent in Academic environment or Regional or Country Pharmaceutical environmentUnderstanding of drug development process over different stagesUnderstanding of companion diagnostic development processExperience of developing and delivering presentations and publications in EnglishStrong written and oral communication skills;Strong Global mindsetUnderstanding of Global regulations and guidelines;Experience of effectively managing risk and compliance issues;Experience of managing teams across cultures and geographies;Experience of participating in cross-functional teams;Experience of working across and building effective working relationships between functions;Proven record of relationship building, both internally and externally to the organization;High degree of fluency in written and verbal English;Great presentation skills. Experience in: - Large Private Practice: Family Medicine, Addiction Medicine, Obesity Medicine, Sports Physicals- Geriatric Care: Hospital/Academic Faculty and Nursing Homes: long term, Subacute and Assisted - School Physician: Sports Medicine Manchester Regional High School Physician-Scientist role: Clinical. Translational & PreClinical Experienced. Innovative in designing, conducting, analyzing toxicology research studies. Evaluating key data in support of the Clinical Trials (FIH and subsequent studies supporting phases II-IV.)Toxicologist Role: Evaluate Drug Safety Profile of Molecular Compounds--> Identifying dose-related target organ toxicityIn-Vivo Research Studies in Rhesus/Cyno Monkeys, Beagel Dogs & Rodents: Acute, Range-finding, ExploratorySub-Chronic, Chronic, Inhalant, IV, Subcutanrous, IM, p/o studies inluding Intermittent-Continuous fusion. Reproductive studies (Teratology / peripost natal toxicity study), Carcenogenic studiesIn-Vitro Toxicology Studies:Cross reactivity study in tissues from non human primates, and mice.PreIND, NDA, BLA filling for new compounds.